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Abstract
The CRISPR/Cas9 system has emerged as an important tool for various genome engineering 
applications. A current obstacle to high throughput applications of CRISPR/Cas9 is the imprecise 
prediction of highly active single guide RNAs (sgRNAs). We previously implemented the 
CRISPR/Cas9 system to induce tissue-specific mutations in the tunicate Ciona. In the present 
study, we designed and tested 83 single guide RNA (sgRNA) vectors targeting 23 genes expressed 
in the cardiopharyngeal progenitors and surrounding tissues of Ciona embryo. Using high-
throughput sequencing of mutagenized alleles, we identified guide sequences that correlate with 
sgRNA mutagenesis activity and used this information for the rational design of all possible 
sgRNAs targeting the Ciona transcriptome. We also describe a one-step cloning-free protocol for 
the assembly of sgRNA expression cassettes. These cassettes can be directly electroporated as 
unpurified PCR products into Ciona embryos for sgRNA expression in vivo, resulting in high 
frequency of CRISPR/Cas9-mediated mutagenesis in somatic cells of electroporated embryos. We 
found a strong correlation between the frequency of an Ebf loss-of-function phenotype and the 
mutagenesis efficacies of individual Ebf-targeting sgRNAs tested using this method. We anticipate 
that our approach can be scaled up to systematically design and deliver highly efficient sgRNAs 
for the tissue-specific investigation of gene functions in Ciona.
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Introduction
A platform for targeted mutagenesis has been recently developed based on the prokaryotic 
immune response system known as CRISPR/Cas (Clustered Regularly Interspaced Short 
Palindromic Repeats/CRISPR-Associated) (Barrangou et al. 2007). In its most common 
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derivation for genome engineering applications, the system makes use of a short RNA 
sequence, known as a single guide RNA (sgRNA) to direct the Cas9 nuclease of 
Streptococcus pyogenes to a specific target DNA sequence. (Jinek et al. 2012; Cong et al. 
2013; Jinek et al. 2013; Mali et al. 2013). Although initial Cas9 binding requires a 
Protospacer Adjacent Motif (PAM) sequence, most commonly “NGG”, the high specificity 
of this system is accounted for by Watson-Crick base pairing between the 5′ end of the 
sgRNA and a 17–20bp “protospacer” sequence immediately adjacent to the PAM (Fu et al. 
2014). Upon sgRNA-guided binding to the intended target, Cas9 generates a double stranded 
break (DSB) within the protospacer sequence. Imperfect repair of these DSBs by non-
homologous end joining (NHEJ) often results in short insertions or deletions (indels) that 
may disrupt the function of the targeted sequence. Numerous reports have confirmed the 
high efficiency of CRISPR/Cas9 for genome editing purposes (Dickinson et al. 2013; 
Hwang et al. 2013; Wang et al. 2013a; Koike-Yusa et al. 2014; Paix et al. 2014; Shalem et al. 
2014; Wang et al. 2014; Gantz and Bier 2015; Sanjana et al. 2016).
The tunicate Ciona is a model organism for the study of chordate-specific developmental 
processes (Satoh 2013). The CRISPR/Cas9 system was adapted to induce site-specific DSBs 
in the Ciona genome (Sasaki et al. 2014; Stolfi et al. 2014). Using electroporation to 
transiently transfect Ciona embryos with plasmids encoding CRISPR/Cas9 components, we 
were able to generate clonal populations of somatic cells carrying loss-of-function mutations 
of Ebf, a transcription-factor-coding gene required for muscle and neuron development, in 
F0-generation embryos (Stolfi et al. 2014). By using developmentally regulated cis-
regulatory elements to drive Cas9 expression in specific cell lineages or tissue types, we 
were thus able to control the disruption of Ebf function with spatiotemporal precision. 
Following this proof-of-principle, tissue-specific CRISPR/Cas9 has rapidly propagated as a 
simple yet powerful tool to elucidate gene function in the Ciona embryo (Abdul-Wajid et al. 
2015; Cota and Davidson 2015; Segade et al. 2016; Tolkin and Christiaen 2016).
We sought to expand the strategy to target more genes, with the ultimate goal of building a 
genome-wide library of sgRNAs for systematic genetic loss-of-function assays in Ciona 
embryos. However, not all sgRNAs drive robust CRISPR/Cas9-induced mutagenesis, and 
few guidelines exist for the rational design of highly active sgRNAs, which are critical for 
rapid gene disruption in F0. This variability and unpredictable efficacy demands 
experimental validation of each sgRNA tested. Individual studies have revealed certain 
nucleotide sequence features that correlate with high sgRNA expression and/or activity in 
CRISPR/Cas9-mediated DNA cleavage (Doench et al. 2014; Gagnon et al. 2014; Ren et al. 
2014; Wang et al. 2014; Chari et al. 2015; Fusi et al. 2015; Housden et al. 2015; Moreno-
Mateos et al. 2015; Wong et al. 2015; Xu et al. 2015; Doench et al. 2016). These studies 
have been performed in different organisms using a variety of sgRNA and Cas9 delivery 
methods and show varying ability to predict sgRNA activities across platforms (Haeussler et 
al. 2016).
Given the uncertainty regarding how sgRNA design principles gleaned from experiments in 
other species might be applicable to Ciona, we tested a collection of sgRNAs using our own 
modified tools for tissue-specific CRISPR/Cas9-mediated mutagenesis in Ciona embryos. 
We describe here the construction and validation of this collection using high-throughput 
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sequencing of PCR-amplified target sequences. This dataset allowed us to develop a 
practical pipeline for optimal design and efficient assembly of sgRNA expression constructs 
for use in Ciona.
Results
High-Throughput sequencing to estimate sgRNA-specific mutagenesis rates
Previous studies using CRIsPR/Cas9-based mutagenesis in Ciona revealed that different 
sgRNAs have varying ability to induce mutations (Sasaki et al. 2014; Stolfi et al. 2014). In 
order to test a larger number of sgRNAs and identify parameters that may influence 
mutagenesis efficacy, we constructed a library of 83 sgRNA expression plasmids targeting a 
set of 23 genes (Table 1). The majority of these genes are transcription factors and signaling 
molecules of potential interest in the study of cardiopharyngeal mesoderm development. The 
cardiopharyngeal mesoderm of Ciona, also known as the Trunk Ventral Cells (TVCs), are 
multipotent cells that invariantly give rise to the heart and pharyngeal muscles of the adult 
(Hirano and Nishida 1997; Stolfi et al. 2010; Razy-Krajka et al. 2014), thus sharing a 
common ontogenetic motif with the cardiopharyngeal mesoderm of vertebrates (Wang et al. 
2013b; Diogo et al. 2015; Kaplan et al. 2015).
We followed a high-throughput-sequencing-based approach to quantify the efficacy of each 
sgRNA, i.e. its ability to cause CRISPR/Cas9-induced mutations in targeted sequences in the 
genome (Figure 1a–c). The 83 sgRNA plasmids were co-electroporated with 
Eef1a1>nls∷Cas9∷nls plasmid. The ubiquitous Eef1a1 promoter is active in all cell lineages 
of the embryo and has been used to express a variety of site-specific nucleases for targeted 
somatic knockouts in Ciona (Sasakura et al. 2010; Kawai et al. 2012; Sasaki et al. 2014; 
Stolfi et al. 2014; Treen et al. 2014). Each individual sgRNA + Cas9 vector combination was 
electroporated into pooled Ciona zygotes, which were then grown at 18°C for 16 hours post-
fertilization (hpf; embryonic stage 25)(Hotta et al. 2007). Targeted sequences were 
individually PCR-amplified from each pool of embryos. Each target was also amplified from 
“negative control” embryos grown in parallel and electroporated with Eef1a1>nls∷Cas9∷nls 
and “U6>Negative Control” sgRNA vector. Agarose gel-selected and purified amplicons 
(varying from 108 to 350 bp in length) were pooled in a series of barcoded “targeted” and 
“negative control” Illumina sequencing libraries and sequenced using the Illumina MiSeq 
platform.
Alignment of the resulting reads to the reference genome sequence (Satou et al. 2008) 
revealed that targeted sites were represented on average by 16,204 reads, with a median of 
3,899 reads each (Supplementary Table 1). The ability of each sgRNA to guide Cas9 to 
induce DSBs at its intended target was detected by the presence of insertions and deletions 
(indels) within the targeted protospacer + PAM. The ratio of [indels]/[total reads] represents 
our estimation of the mutagenesis efficacy of the sgRNA (Figure 1b–d, Supplementary Table 
1). For each mutation, an unknown number of cell divisions occur between the moment 
Cas9 induces a DSB and the time of sample collection and genomic DNA extraction. This 
prevents us from quantifying the true mutagenesis rates. However, we can surmise that this 
applies comparably to all sgRNAs, such that our values still represent an accurate ranking of 
mutagenesis efficacy.
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For simplicity, we did not count single nucleotide point mutations, even though a fraction of 
them may result from NHEJ-repair of a DSB event. Our data indicated that all sgRNAs (with 
the exception of Neurog.2) were able to induce DSBs, with estimated efficacies varying 
from 0.05% (Ebf.4) to 59.63% (Htr7-r.2). Although each sgRNA was tested only once, we 
did not observe any evidence of electroporation variability or batch effects that may have 
confounded our estimates (Supplementary Figure 1).
This conservative approach most likely underestimates the actual mutagenesis rates. First, 
we excluded point mutations potentially resulting from imperfect DSB repair. Second, but 
more importantly, amplicons from transfected cells are always diluted by wild-type 
sequences from untransfected cells in the same sample, due to mosaic incorporation of 
sgRNA and Cas9 plasmids. Indeed, we previously observed an enrichment of mutated 
sequences amplified from reporter transgene-expressing cells isolated by magnetic-activated 
cell sorting (representing the transfected population of cells) relative to unsorted cells 
(representing mixed transfected and untransfected cells) (Stolfi et al. 2014). In that particular 
example, the estimated mutagenesis efficacy induced by the Ebf.3 sgRNA was 66% in sorted 
sample versus 45% in mixed sample. This suggests the actual efficacies of some sgRNAs 
may be up to 1.5-fold higher than their estimated rates.
Analysis of unique indels generated by the activity of two efficient sgRNAs, Ebf.3 and 
Lef1.2, indicated a bias towards deletions rather than insertions, at a ratio of roughly 2:1 
deletions:insertions (Figure 1e). However, these two sgRNAs generated different 
distributions of indel lengths, indicating indel position and size may depend on locus-
specific repair dynamics as previously shown (Bae et al. 2014).
Numerous studies have reported the potential off-target effects of CRISPR/Cas9 in different 
model systems (Fu et al. 2013; Hsu et al. 2013; Pattanayak et al. 2013; Cho et al. 2014). For 
this study, we were able to mostly select highly specific sgRNAs, owing to the low 
frequency of predicted off-target sequences in the small, A/T-rich Ciona genome (see 
Discussion for details). To test the assumption that off-target DSBs are unlikely at partial 
sgRNA seed-sequence matches, we analyzed the mutagenesis rates at two potential off-
target sites that matched the protospacer at the 10 and 8 most PAM-proximal positions of the 
Ebf.3 and Fgf4/6.1 sgRNAs, respectively. We did not detect any mutations in 5,570 and 
6,690 reads mapped to the two loci, respectively, suggesting high specificity of the 
sgRNA:Cas9 complex to induce DSBs only at sites of more extensive sequence match.
Identifying sequence features correlated with sgRNA efficacy
We analyzed our dataset for potential correlations between target sequence composition and 
sgRNA-specific mutagenesis rate (excluding the Bmp2/4.1 sgRNA because only two reads 
mapped to its target sequence). We hypothesized that, if mutagenesis efficacy can be 
predicted by nucleotide composition at defined positions in the protospacer and flanking 
sequences, then comparing the target sequences of the most or least active sgRNAs in our 
dataset should reveal features that affect CRISPR/Cas9 efficacy in Ciona. To that effect, we 
performed nucleotide enrichment analyses for the top and bottom 25% sgRNAs ranked by 
measured mutagenesis efficacy (Figure 2)(Schneider and Stephens 1990; Crooks et al. 
2004). For the top 25% sgRNAs, guanine was overrepresented in the PAM-proximal region, 
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while the ambiguous nucleotide of the PAM (‘N’ in ‘NGG’) was enriched for cytosine. We 
also observed an overall depletion of thymine in the protospacer sequence for the top 25% 
sgRNAs, likely due to premature termination of PolIII-driven transcription as previously 
demonstrated (Wu et al. 2014). Among the bottom 25% sgRNAs, we observed a higher 
representation of cytosine at nucleotide 20 of the protospacer (Figure 2). All these 
observations are consistent with the inferences drawn from previous studies, suggesting that 
certain sgRNA and target sequence features that influence Cas9:sgRNA-mediated 
mutagenesis rates are consistent across different experimental systems (Gagnon et al. 2014; 
Ren et al. 2014; Wu et al. 2014; Chari et al. 2015; Moreno-Mateos et al. 2015; Haeussler et 
al. 2016).
Several studies in different model organisms have similarly examined the nucleotide 
preferences amongst sgRNAs inducing high or low rates of mutagenesis, and put forth 
predictive heuristics and/or algorithms for the rational design of highly active sgRNAs 
(Doench et al. 2014; Gagnon et al. 2014; REN et al. 2014; WANG et al. 2014; CHARI et al. 
2015; FUSI et al. 2015; HOUSDEN et al. 2015; Moreno-Mateos et al. 2015; Wong et al. 
2015; Xu et al. 2015; Doench et al. 2016). These various algorithms have been evaluated, 
summarized, and aggregated by the CRISPR sgRNA design web-based platform CRISPOR 
(Haeussler et al. 2016). According to this metaanalysis, the “Fusi/Doench” algorithm (“Rule 
Set 2”)(FUSI et al. 2015; DOENCH et al. 2016) is the best at predicting the activities of 
sgRNA transcribed in vivo from a U6 small RNA promoter transcribed by RNA Polymerase 
III (PolIII), while CRISPRscan is recommended for sgRNAs transcribed in vitro from a T7 
promoter (Moreno-Mateos et al. 2015).
Ciona rearing conditions differ from most other model systems, being a marine invertebrate 
that develops optimally at 16–24°C (Bellas et al. 2003). Moreover, most CRISPR/Cas9-
based experiments in Ciona rely on in vivo transcription of sgRNAs built with a modified “F
+E” backbone (Chen et al. 2013) by a Ciona-specific U6 promoter (Nishiyama and Fujiwara 
2008). We used CRISPOR to calculate predictive scores for all sgRNAs in our data set and 
compare these scores to our mutagenesis efficacy measurements for each (Figure 3a, 
Supplementary Table 1). We found that indeed the Fusi/Doench score best correlated with 
our measured sgRNA efficacies, with a Spearman’s rank correlation coefficient (rho) of 
0.435 (p=3.884e-05)(Figure 3a). CRISPRscan, the algorithm based on in vitro-, T7-
transcribed sgRNAs injected into zebrafish, was less predictive (rho = 0.344, p=0.001435)
(Supplementary Table 1), supporting the conclusion that sgRNA expression method (e.g. U6 
vs. T7) accounts for an important parameter when choosing an sgRNA design algorithm. 
Scores computed by other published algorithms available on the CRISPOR platform did not 
yield good correlations with our measurements (Supplementary Table 1), indicating these 
are perhaps not suited for predicting sgRNA activity in Ciona.
In a previous study, highly penetrant, tissue-specific loss-of-function phenotypes in F0 
embryos were elicited using the Ebf.3 sgRNA (Stolfi et al. 2014), which in our current study 
had a measured mutagenesis efficacy of 37%. Further comparison of measured mutagenesis 
efficacy and mutant phenotype frequency for a series of Ebf-targeting sgRNAs revealed that 
an estimated sgRNA efficacy at least 25% correlated with over 70% reduction in the 
frequency of embryos expressing an Islet reporter construct (see below and Figure 6). We 
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thus reasoned that a mutagenesis efficacy of ~25% would be the minimum threshold of 
acceptable sgRNA activity for loss-of-function assays in F0. Within our dataset, among the 
sgRNAs that had a Fusi/Doench score >60, 18 of 23 (78%) had a mutagenesis efficacy rate 
over 24% (Figure 3b). In contrast, only 8 of 25 (32%) of sgRNAs with a Fusi/Doench score 
<50 had an efficacy over 24% (Figure 3b). Indeed, a receiver operating characteristic (RoC) 
analysis showed an area under the curve (AUC) of 0.77 when using Fusi/Doench score as a 
classifier of “good” (>24.5% efficacy) vs. “bad” (≤24.5%) sgRNAs (Figure 3c). The most 
accurate Fusi/Doench score cutoffs appeared to be between 50 and 55, when taking both 
specificity and sensitivity into account (Supplementary Table 2, Supplementary Figure 2). 
However, if the number of candidate sgRNAs is not limiting, it may be more desirable to use 
a Fusi/Doench score cutoff of 60 in order to avoid false positives (i.e., sgRNAs that are 
predicted as “good” when in reality they are “bad”). Thus, for Ciona, we recommend using 
CRISPOR to select sgRNAs with Fusi/Doench scores >60 and avoid those with Fusi/Doench 
<50. We believe this approach will significantly streamline the search for suitable U6 
promoter-driven sgRNAs targeting one’s gene of interest.
Multiplexed targeting with CRISPR/Cas9 generates large deletions in the Ciona genome
Large deletions of up to 23 kb of intervening DNA resulting from NHEJ between two 
CRISPR/Cas9-induced DSBs have been reported in Ciona (Abdul-Wajid et al. 2015). For 
functional analyses of protein-coding genes, such deletions would more likely produce null 
mutations than small deletions resulting from the action of lone sgRNAs. To test whether we 
could cause tissue-specific large deletions in F0 embryos, we targeted the forkhead/winged 
helix transcription-factor-encoding gene Foxf (Figure 4a), which contributes to 
cardiopharyngeal development in Ciona (Beh et al. 2007). We co-electroporated 
Eef1a1>nls∷Cas9∷nls with sgRNA vectors Foxf.4 and Foxf.2 (with induced mutagenesis 
rates of 39% and 18%, respectively). We extracted genomic DNA from electroporated 
embryos and PCR-amplified the sequence spanning both target sites. We obtained a specific 
~300 bp PCR product corresponding to the amplified region missing the ~2.1 kbp of 
intervening sequence between the two target sites (Figure 4b). Cloning the deletion band and 
sequencing individual clones confirmed that the short PCR product corresponds to a deletion 
of most of the Foxf first exon and 5′ cis-regulatory sequences (Beh et al. 2007). We did not 
detect this deletion using genomic DNA extracted from embryos electroporated with either 
sgRNA alone. Similar deletion PCR products were observed, cloned, and sequenced for 
other genes including Nk4, Fgfr, Mrf, Htr7-related, Bmp2/4, and Hand, using pairs of highly 
mutagenic sgRNAs (Supplementary Figure 3). The largest deletion recorded was ~3.6 kbp, 
with sgRNAs Nk4.2 (46% efficacy) and Nk4.3 (38% efficacy), entirely removing the sole 
intron of Nk4 and small portions of the flanking exons. The sgRNAs targeting Mrf were 
shown to inhibit its function and subsequent siphon muscle development (Tolkin and 
Christiaen 2016).
Foxf is expressed in TVCs and head epidermis (Figure 4c), the latter of which is derived 
exclusively from the animal pole (Nishida 1987; Imai et al. 2004; Pasini et al. 2006; Beh et 
al. 2007). Because the ~2.1 kbp deletion introduced in the Foxf locus excised the epidermal 
enhancer and basal promoter (Beh et al. 2007), we sought to examine the effects of these 
large deletions on Foxf transcription. We used the cis-regulatory sequences from Zfpm (also 
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known as Friend of GATA, or Fog, and referred to as such from here onwards) to drive Cas9 
expression in early animal pole blastomeres (Rothbächer et al. 2007). We electroporated 
Fog>nls∷Cas9∷nls together with Foxf.2 and Foxf.4 sgRNA vectors and Fog>H2B∷mCherry, 
and raised embryos at 18°C for 9.5 hpf (early tailbud, embryonic stage 20). We performed 
whole mount mRNA in situ hybridization to monitor Foxf expression, expecting it to be 
silenced in some epidermal cells by tissue-specific CRISPR/Cas9-induced deletions of the 
Foxf cis-regulatory sequences on both homologous chromosomes in each cell. Indeed, we 
observed patches of transfected head epidermal cells (marked by H2B∷mCherry) in which 
Foxf expression was reduced or eliminated (Figure 4d). This was in contrast to the uniform, 
high levels of Foxf expression observed in “control” embryos electroporated with Ebf.3 
sgRNA (Ebf is unlikely to be involved in Foxf regulation in the epidermis where it is not 
expressed, Figure 4c). Taken together, these results indicate that, by co-electroporating two 
or more highly active sgRNAs targeting neighboring sequences, one can frequently generate 
large deletions in the Ciona genome in a tissue-specific manner.
Rapid generation of sgRNA expression cassettes ready for embryo transfection
CRISPR/Cas9 is an efficient and attractive system for targeted mutagenesis in Ciona, but 
cloning individual sgRNA vectors is a labor-intensive, rate-limiting step. To further expedite 
CRISPR/Cas9 experiments, we adapted a one-step overlap PCR (OSO-PCR) protocol to 
generate U6 promoter>sgRNA expression “cassettes” for direct electroporation without 
purification (Figure 5, Supplementary Figure 4, see Materials and Methods and 
Supplementary Protocol for details). We tested the efficacy of sgRNAs expressed from these 
unpurified PCR products, by generating such expression cassettes for the validated Ebf.3 
sgRNA. We electroporated Eef1a1>nls∷Cas9∷nls and 25 μl (corresponding to ~2.5 μg, see 
Materials and Methods and Supplementary Figure 5) of unpurified, U6>Ebf.3 sgRNA 
OSO-PCR or U6>Ebf.3 sgRNA traditional PCR products (total electroporation volume: 700 
μl). Next-generation sequencing of the targeted Ebf.3 site revealed mutagenesis rates similar 
to those obtained with 75 μg of U6>Ebf.3 sgRNA plasmid (Supplementary Table 1). This 
was surprising given the much lower total amount of DNA electroporated from the PCR 
reaction relative to the plasmid prep (2.5 μg vs. 75 μg). This discrepancy could indicate a 
higher efficiency of transcription of linear vs. circular transfected DNA, though more 
thorough analyses are warranted to investigate the behavior of linear DNA in Ciona 
embryos.
To assess whether unpurified sgRNA PCR cassettes could be used in CRISPR/Cas9-
mediated loss-of-function experiments in F0 embryos, we assayed the expression of an Islet 
reporter transgene in MN2 motor neurons (RYAN et al. 2016), which depends upon Ebf 
function (STOLFI et al. 2014). Indeed, Islet>GFP expression was downregulated in embryos 
electroporated with Sox1/2/3>nls∷Cas9∷nls and 25 μl of unpurified U6>Ebf.3 traditional 
PCR or 25μg U6>Ebf.3 plasmid, but not with 25 μl (~2.5 μg) of unpurified U6>Negative 
Control sgRNA PCR cassette (Figure 6a–d). Taken together, these results indicate that 
unpurified PCR products can be used in lieu of plasmids to express sgRNAs for tissue-
specific CRISPR/Cas9-mediated mutagenesis in Ciona embryos.
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Correlation between sgRNA efficacy and mutant phenotype penetrance
Since we measured a wide range of mutagenesis efficacies across our library of 83 sgRNAs, 
we wanted to assess how this variability correlates with mutant phenotype penetrance. One 
possibility is that sgRNA efficacies and frequencies of mutant phenotypes in F0 are linearly 
correlated. Alternatively, mutant phenotypes might only be observed at distinct thresholds of 
sgRNA activity.
To test this, we designed 7 additional sgRNAs (Ebf.A through Ebf.G) targeting the IPT and 
HLH domain-coding exons of Ebf (Figure 6a,e, Supplementary Table 3). We generated these 
sgRNA expression cassettes by OSO-PCR, and co-electroporated 25 μl of each reaction with 
either 25 μg Eef1a1>nls∷Cas9∷nls (for mutagenesis efficacy sequencing) or 40 μg 
Sox1/2/3>nls∷Cas9∷nls + 15 μg Sox1/2/3>H2B∷eGFP + 40 μg Islet>mCherry (for 
phenotype assay). sgRNA efficacies were measured by direct Sanger sequencing of the 
target region PCR-amplified from larvae electroporated with the former combination (see 
Materials and methods for details), and Islet>mCherry expression in H2B∷eGFP+ motor 
neurons was scored in larvae electroporated with the latter mix.
Quantification of indel-shifted electrophoresis chromatogram peaks (“Peakshift” assay) 
revealed sgRNA mutagenesis efficacies ranging from 5% to 43% (Figure 6e, Supplementary 
Table 3). Of note, the sgRNA with the lowest efficacy (Ebf.E) was clearly hampered by a 
naturally occurring SNP that eliminates the PAM (NGG to NGA) in a majority of 
haplotypes. In parallel, the proportion of transfected embryos Islet>mCherry expression was 
observed to vary between 0% and 94%. When this was plotted against the measured 
mutagenesis efficacies, we observed a nearly perfect linear correlation between the mutant 
phenotype (loss of Islet>mCherry expression) and Ebf mutagenesis (Figure 6e, 
Supplementary Table 3). Taken together, these results suggest that highly efficient sgRNAs 
can be generated from OSO-PCR cassettes and validated for loss-of-function studies by 
Sanger sequencing. The Sanger sequencing-based peakshift assay is highly reproducible and 
approximates the efficacy rates estimated by NGS (Supplementary Table 6). As such, we 
recommend the peakshift assay as a cheap, fast alternative for testing sgRNA activity in 
Ciona embryos.
Genome-wide design and scoring of sgRNAs for Ciona
While Ciona researchers will find the Fusi/Doench scoring system and the OSO-PCR 
method useful for sgRNA expression cassette design and assembly, we hoped to further 
empower the community by pre-emptively designing all possible sgRNAs with a unique 
target site within 200 bp of all Ciona exonic sequences. We computationally identified 
3,596,551 such sgRNAs. We have compiled all sgRNA sequences and their corresponding 
specificity and efficiency scores (including Fusi/Doench). They are available as a UCSC 
Genome Browser track for the Ci2 genome assembly (http://genome.ucsc.edu/)[FOR PEER 
REVIEW ONLY: http://genome-test.soe.ucsc.edu], with links to CRISPOR for off-target 
prediction and automated OSO-PCR primer design. This track is freely available for 
download to use on other browsers, like those of specific interest to the tunicate community 
such as ANISEED (Brozovic et al. 2015) or GHOST (Satou et al. 2005).
Gandhi et al. Page 8
Dev Biol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Discussion
We have built a library of 83 plasmid vectors for the in vivo expression of sgRNAs targeting 
23 genes expressed in the cardiopharyngeal mesoderm and surrounding tissues, mostly 
hypothesized to be involved in regulating the specification of heart and/or pharyngeal 
muscles in Ciona, even though many have complex expression patterns and probably 
pleiotropic functions. We have also established reliable protocols for the validation of 
sgRNA efficacy in electroporated Ciona embryos by either next-generation sequencing or 
Sanger sequencing. This has allowed us to estimate the activity of all these sgRNAs, which 
are ready to be used for ongoing and future functional studies.
By analyzing correlations between target sequence nucleotide composition and sgRNA 
mutagenesis efficacy, we identified sgRNA sequence features that may contribute to 
Cas9:sgRNA activity. Some of these sequence features have been identified in previous 
CRISPR/Cas9-mediated mutagenesis screens performed in other metazoan model 
organisms, suggesting that these are determined by the intrinsic properties of sgRNAs and/or 
Cas9 (Doench et al. 2014; Gagnon et al. 2014; Ren et al. 2014; Chari et al. 2015; Moreno-
Mateos et al. 2015). For instance, sgRNA efficacy is correlated with increased guanine 
content in the PAM-proximal nucleotides of the sgRNA, postulated to be due to increased 
sgRNA stability by G-quadruplex formation (Moreno-Mateos et al. 2015). This would 
explain the specific enrichment for guanine but not cytosine, even if both could in theory 
augment sgRNA folding or binding to target DNA. We also encountered a depletion of 
thymine and cytosine in the PAM-proximal nucleotides of the protospacers for highly active 
sgRNAs. The strong negative correlation between sgRNA efficacy and thymine content of 
the protospacer is easily attributed to our use of the PolIII-dependent U6 promoter to express 
our sgRNAs. It has been shown that termination of transcription by PolIII can be promoted 
by degenerate poly-dT tracts (NIELSEN et al. 2013). A high number of non-consecutive 
thymines clustered in the protospacer could thus result in lower sgRNA expression level due 
to premature termination of sgRNA transcription (STOLFI et al. 2014; Wu et al. 2014). 
Similarly, adenines are thought to contribute to the instability of sgRNAs (Moreno-Mateos et 
al. 2015), suggesting that CRISPR/Cas9 mutagenesis efficacies might be primarily 
determined by sgRNA transcription and degradation rates, which will vary depending on the 
species studied and the mode of sgRNA delivery (e.g. in vitro vs. in vivo synthesis).
Despite the lack of biological replicates for the NGS-based measurements, we have 
presented different data suggesting that sgRNA mutagenesis efficacies are reproducible 
between experiments, and not greatly affected by electroporation variability. First and 
foremost, we found a high correlation (Spearman’s rank correlation coefficient of 0.435, 
p=3.884e-05) between our NGS data and scores from the predictive Fusi/Doench algorithm 
(Figure 3). One would expect little correlation between our NGS data and predicted scores 
(by any algorithm) if the variation observed in our data were caused by technical variability 
and not innate sgRNA efficacy. Second, all three Ebf.3 sgRNA vector formats (plasmid, 
traditional PCR cassette, OSO-PCR cassette) resulted in very similar mutagenesis efficacies 
by NGS (30.2%–37.3%), Supplementary Table 1). Third, there was a high correlation 
between mutagenesis efficacies of Ebf-targeting sgRNAs and Ebf loss-of-function 
phenotypes, which were assayed in two separate sets of experiments (Figure 6e). Lastly, 
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there was little variability in efficacy between biological replicates of a subset of sgRNAs as 
measured by peakshift (Supplementary Table 6).
Although more replicates and better statistical support would be required to develop a 
Ciona-specific sgRNA prediction algorithm de novo, we believe our data are accurate 
enough to support using the Fusi/Doench algorithm as the gold-standard in sgRNA design 
for Ciona (Figure 3). Among the various published sgRNA prediction algorithms, Fusi/
Doench (FUSI et al. 2015; DOENCH et al. 2016) functions well as a classifier for “good” 
(>24.5% mutagenesis efficacy) and “bad” (<24.5%) sgRNAs. Despite these general trends, 
several sgRNAs defied this algorithm-based prediction. This suggests that there are multiple, 
possibly additive or synergistic factors that determine the mutagenesis efficacy, only one of 
which is primary sequence composition of the sgRNA or target. Other factors that can 
influence Cas9 binding include chromatin accessibility and nucleosome occupancy (Wu et 
al. 2014; HINZ et al. 2015; HORLBECK et al. 2016; ISAAC et al. 2016). What other 
additional factors contribute to variability of in vivo sgRNA mutagenesis efficacies will be 
an important topic of study as CRISPR/Cas9-based approaches are expanded to address 
additional questions in basic research as well as for therapeutic purposes.
While an optimized predictive algorithm for Ciona-specific sgRNA design remains a 
desirable goal, our current approach should help other researchers to identify, with greater 
confidence, which sgRNAs are likely to confer enough mutagenic activity for functional 
studies in F0. We have shown, using a series of Ebf-targeting sgRNAs and an Ebf loss-of-
function readout assay (Islet reporter expression) that a linear correlation exists between 
sgRNA mutagenesis efficacy and the probability of somatic gene knockout in F0. In this 
case, we measured the frequency of a binary loss-of-function assay (Islet ON or OFF) in a 
large population of embryos. Therefore it is expected that the probability a homozygous Ebf 
knockout (resulting in Islet OFF phenotype) should be correlated to the observed frequency 
of Ebf mutations in somatic cell populations. While Ebf function can be disrupted by small 
changes to its crucial IPT/HLH domains, other genes may prove harder to disrupt with the 
short indels generated by CRISPR/Cas9. However, we show that the combinatorial action of 
two or more sgRNAs can result in high frequency of large deletions spanning many kbp, 
which should help generate loss-of-function alleles for such recalcitrant genes.
Despite legitimate concerns about potential off-target effects for functional studies, we were 
not able to detect CRISPR/Cas9-mediated mutagenesis at two potential off-target sites for 
the sgRNAs Ebf.3 and Fgf4/6.1. For the remainder of the sgRNAs, we purposefully selected 
those with no strongly predicted off-targets. This was possible in Ciona due to two factors. 
First, the Ciona genome is significantly smaller than the human genome and most 
metazoans, resulting in a lower number of similar protospacer sequences. Second, the GC 
content of the Ciona genome is only 35% as compared to 65% in humans, which should 
result in a lower overall frequency of canonical PAMs (NGG). Based on these 
considerations, we predict off-target effects to be less pervasive in Ciona than in other model 
organisms with more complex, GC-rich genomes.
Even with improved prediction of sgRNA efficacy and specificity, there is still a need to test 
several sgRNAs to identify the optimal one targeting a gene of interest. To this end, we have 
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developed a cloning-free OSO-PCR method for the rapid assembly of sgRNA expression 
cassettes. We have shown that these unpurified PCR cassettes can be directly electroporated 
into Ciona embryos and screened by either Sanger sequencing of target sequences or mutant 
phenotype frequency in F0. The automated design of primers for Ciona-specific sgRNA 
cassette OSO-PCR has been implemented in the latest version (v4.0) of CRISPOR (http://
crispor.tefor.net/).
Finally, we have pre-emptively designed all possible sgRNAs targeting exonic sequences in 
the compact Ciona genome and calculated their specificity and efficiency by various 
predictive algorithms. This track is available online on the UCSC genome browser, but is 
also freely available for download and use with other genome browsers. This allows 
researchers to locally browse for sgRNAs with predicted high activity targeting their loci of 
interest. Integration with the CRISPOR website further allows SNP and off-target prediction, 
and pre-designed OSO-PCR oligonucleotide primers for rapid, efficient synthesis and 
transfection. We expect these resources to facilitate the scaling of CRISPR/Cas9-mediated 
targeted mutagenesis and enable genome-wide screens for gene function in Ciona.
Materials and Methods
Target sequence selection and sgRNA design
23 genes from Ciona robusta (formerly Ciona intestinalis type A)(HOSHINO AND 
TOKIOKA 1967; BRUNETTI et al. 2015) hypothesized to be important for 
cardiopharyngeal mesoderm development were shortlisted (Table 1) and one to four sgRNAs 
targeting non-overlapping sequences per gene were designed, for a total of 83 sgRNA 
vectors (Supplementary Table 3). Two sgRNAs were designed to target the neurogenic 
bHLH factor Neurogenin, a gene that is not expressed in the cardiopharyngeal mesoderm 
and is not thought to be involved in cardiopharyngeal development. Target sequences were 
selected by searching for N19+NGG (protospacer + PAM) motifs and screened for 
polymorphisms and off-target matches using the GHOST genome browser and BLAST 
portal (Satou et al. 2005; Satou et al. 2008). Potential off-targets were also identified using 
the CRISPRdirect platform (Naito et al. 2015). sgRNA expression plasmids were designed 
for each of these protospacers and constructed using the U6>sgRNA(F+E) vector as 
previously described (Stolfi et al. 2014), as well as a “Negative Control” protospacer that 
does not match any sequence in the C. robusta genome (5′-
GCTTTGCTACGATCTACATT-3′). Stretches of more than four thymine bases (T) were 
avoided due to potential premature transcription termination. Candidate sgRNAs with a 
partial PAM-proximal match of 13 bp or more to multiple loci were also discarded due to 
off-target concerns. All sgRNAs were designed to target protein-coding, splice-donor, or 
splice-acceptor sites, unless specifically noted. We preferred more 5′ target sites, as this 
provides a greater probability of generating loss-of-function alleles.
Electroporation of Ciona embryos
DNA electroporation was performed on pooled, dechorionated zygotes (1-cell stage 
embryos) from C. robusta adults collected from San Diego, CA (M-REP) as previously 
described (Christiaen et al. 2009). All sgRNA plasmid maxipreps were individually 
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electroporated at a final concentration of 107 ng/μl (75 μg in 700 μl) concentration together 
with Eef1a1>nls∷Cas9∷nls plasmid (Stolfi et al. 2014) at 35.7 ng/μl (25 μg in 700 μl) 
concentration. For testing U6>Ebf.3 PCR or OSO-PCR, 25 μl was used instead of sgRNA 
plasmid. Embryos were then rinsed once in artificial sea water, to remove excess DNA and 
electroporation buffer, and grown at 18°C for 16 hours post-fertilization.
Embryo lysis
After 16 hpf, each pool of embryos targeted with a single sgRNA + Cas9 combination was 
washed in one sea water exchange before lysis, to remove excess plasmid DNA, and 
transferred to a 1.7 ml microcentrifuge tube. Excess sea water was then removed and 
embryos were lysed in 50 μl of lysis mixture prepared by mixing 500 μL of DirectPCR Cell 
Lysis Reagent (Viagen Biotech Inc., Los Angeles, CA, Cat # 301-C) with 1 μl of Proteinase 
K (20 mg/ml, Life Technologies, Carlsbad, CA). The embryos were thoroughly mixed in 
lysis mixture and incubated at 68°C for 15 minutes, followed by 95°C for 10 minutes.
PCR amplification of targeted sequences
Targeted sequences were individually PCR-amplified directly from lysate from embryos 
targeted with the respective sgRNA, and from “negative control” lysate (from embryos 
electroporated with Eef1a1>nls∷Cas9∷nls and U6>Negative Control sgRNA vector). Primers 
(Supplementary Table 4) were designed to flank target sites as to obtain PCR products in the 
size range of 108–290bp with an exception of the sequence targeted by Ebf.3 (“Ebf.774” in 
Stolfi et al. 2014) and Ebf.4 sgRNAs, for which the designed primers resulted in a product 
size of 350 bp. Potential off-target sites predicted for sgRNAs Ebf.3 
(CTCGCAACGGGGACAACAGGGGG, genome position KhC8:2,068,844-2,068,866) and 
Fgf4/6.1 (TATTTTAATTCTGTACCTGTGGG, genome position 
KhC9:6,318,421-6,318,443) were amplified to test for off-target CRISPR/Cas9 activity with 
the primers: 5′-CCAGCACTTCAGAGCAATCA-3′ and 5′-
TGACGTCACACTCACCGTTT-3′ (Ebf.3), and 5′-AACGATTGTCCATACGAGGA-3′ 
and 5′-ACTTCCCAACAGCAAACTGG-3′ (Fgf/6.1).
For each targeted sequence, 12.5 μL PCR reactions were set up with final concentrations of 
600 nM each primer, 300 μM dNTPs, 1 mM MgSO4, 2X buffer, and 0.05 U/μl Platinum Pfx 
DNA polymerase (Life Technologies), and subjected to the following PCR program: an 
initial cycle of 10 minutes at 95°C, followed by 30 cycles of 30 seconds at 94°C, 30s at 60°C 
and 30s at 68°C, and a final cycle of 3 minutes at 68°C. PCR reactions were quickly checked 
on an agarose gel for the presence/absence of amplicon. Those that resulted in a single band 
were not initially purified. For those reactions with more than one band, the correct 
amplicon (selected based on expected size) was gel purified using a Nucleospin Gel Clean-
up Kit (Macherey-Nagel, Duren, Germany). Purified and unpurified PCR products were then 
pooled for subsequent processing. The majority of PCR products amplified from larvae 
treated with Cas9 + gene-targeting sgRNA were pooled in Pool 1. All products from larvae 
treated with Cas9 + “negative control” sgRNA were pooled in Pool 2. For those sequences 
targeted by distinct sgRNAs but amplified using the same set of flanking primers, their PCR 
products were split into separate pools, as to allow for separate efficacy estimates.
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Sequencing library preparation
The PCR product pools were electrophoresed on ethidium bromide-stained, 1% agarose gel 
in 0.5X Tris-Acetate-EDTA (TAE) buffer and a band of ~150–300 bp was excised 
(Nucleospin gel and PCR cleanup kit, Macherey-Nagel). 102–235 ng of each pool was used 
as a starting material to prepare sequencing libraries (protocol adapted from http://
wasp.einstein.yu.edu/index.php/Protocol:directional_WholeTranscript_seq). Ends were 
repaired using T4 DNA polymerase (New England Biolabs, Ipswich, MA) and T4 
Polynucleotide Kinase (New England Biolabs), and then A-tailed using Klenow fragment 
(3′→5′ exo-) (New England Biolabs) and dATP (Sigma-Aldrich, St. Louis, MO). Each 
pool was then ligated to distinct barcoded adapters. (NEXTflex DNA Barcodes - BioO 
Scientific Cat# 514101). The six barcodes used in this study were: CGATGT, TGACCA, 
ACAGTG, GCCAAT, CAGATC and CTTGTA. At this step, the adapter-ligated DNA 
fragments were purified twice using Ampure XP beads (Beckman Coulter, Brea, CA). The 
final amplification, using primers included with NEXTflex adapters, was done using the 
PCR program: 2 minutes at 98°C followed by 8 cycles of 30 seconds at 98°C; 30 seconds at 
60°C; 15 seconds of 72°C, followed by 10 minutes at 72°C. Ampure XP bead-based 
selection was performed twice, and the libraries were quantified using qPCR. The libraries 
were then mixed in equimolar ratio to get a final DNA sequencing library concentration of 4 
nM. The multiplexed library was sequenced by Illumina MiSeq V2 platform (Illumina, San 
Diego, CA) using 2×250 paired end configuration.
Next generation sequencing data analysis
FastQ files obtained from sequencing were de-multiplexed and subjected to quality control 
analysis. FastQ reads were mapped to the 2008 KyotoHoya genome assembly (Satou et al. 
2008) by local alignment using Bowtie2.2 (Langmead and Salzberg 2012). Single end reads 
were also mapped to a reduced genome assembly consisting of only those scaffolds 
containing the targeted genes. This allowed for a much faster and accurate alignment using 
Bowtie2.2. The SAM file generated was converted into a BAM file using samtools (Li et al. 
2009). The BAM file was sorted and indexed to visualize reads on Integrative Genomics 
Viewer (IGV) (Robinson et al. 2011). Most mutagenesis rates were obtained by counting 
indels in IGV. For some targets with partially overlapping aplicon sequences, custom Python 
scripts were written to parse the BAM file to get estimated rate of mutagenesis. Since a 
successful CRISPR/Cas9-mediated deletion or insertion should eliminate or disrupt all or 
part of the protospacer + PAM sequence (jointly termed the “pineapple”), we simply looked 
for mapped reads in which the pineapple was not fully present. When appropriate, the rate of 
naturally occurring indels around each target, as detected in reads from “negative control” 
embryos, was subtracted from the raw efficacy rates. Custom python scripts used are 
available upon request. Matplotlib (http://matplotlib.org) was used for plotting, Numpy 
(http://numpy.org) and Pandas (http://pandas.pydata.org) were used for data mining. All 
predictive algorithm scores were generated using CRISPOR (http://crispor.tefor.net/)
(HAEUSSLER et al. 2016).
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Nucleotide Enrichment Analysis
We used log-odds score as a measure to estimate how enriched each nucleotide was at a 
given position in the 43bp region of interest (excluding position 1 of the protospacer, and the 
‘GG’ of the PAM). Log-odds score was defined as the base-2 logarithm of the ratio of 
probability of observing nucleotide ‘N’ at position ‘x,’ and the background probability of 
observing nucleotide ‘N’ by random chance, given its frequency in our sample space (all 
sgRNA targets, n=83). A positive or negative log-odds score reflects enrichment or 
depletion, respectively, of each nucleotide at a given position.
Mathematically,
px = probability of finding nucleotide ‘N’ at position ‘x’
pb = background probability of finding nucleotide ‘N’ at position ‘x’ by chance
Receiver Operating Characteristic (ROC) curve
For a binary classifier (“good” vs. “bad” sgRNA), there are four possible outcomes: True 
Positive (TP), False Positive (FP), True Negative (TN), and False Negative (FN). If the 
predicted classification of the sgRNA by our model was “good” or “bad”, and it was 
supported by our experimental data (i.e. the empirical mutagenesis rate was above or below 
24.5% respectively), it was marked as a “True Positive” or a “True Negative,” respectively. 
If the experimental data failed to support it, it was marked as a “False Positive” or a “False 
Negative,” respectively. The true positive rate (TPR), or “Sensitivity”, was defined as the 
proportion of empirically good sgRNAs that were correctly predicted as good [TPR = 
TP/(TP + FN)]. Similarly, the true negative rate (TNR), or “Specificity”, was defined as the 
proportion of empirically bad gRNAs that were correctly predicted as bad [TNR = TN/(TN 
+ FP)]. The false positive rate (FPR) is 1 - Specificity. In figure 3c, we plotted the true 
positive rates against the false positive rates, all obtained by applying different Fusi/Doench 
score thresholds (ranging from 0 to 100) to the predictions generated by our model (see 
Supplementary Table 2).
Combinatorial sgRNA electroporation to induce large deletions
Embryos were electroporated with 25 μg Eef1a1>nls∷Cas9∷nls and two vectors from the set 
of validated sgRNA plasmids for each targeted gene (50 μg per sgRNA vector). Embryos 
were grown for 12 hpf at 18°C, pooled, and genomic DNA extracted from them using 
QIAamp DNA mini kit (Qiagen). Deletion bands were amplified in PCR reactions using Pfx 
platinum enzyme as described above (see “PCR amplification of targeted sequences”) and 
a program in which the extension time was minimized to 15 seconds only, in order to 
suppress the longer wild-type amplicon and promote the replication of the smaller deletion 
band. Primers used were immediately flanking the sequences targeted by each pair of 
sgRNAs (Supplementary Table 4). Products were purified from agarose gels, A-overhung 
and TOPO-cloned. Colonies were picked, cultured, prepped and sequence.
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Synthesis and electroporation of unpurified sgRNA PCR expression cassettes
U6>Eb/.3 and U6>Negative Control sgRNA expression cassettes were amplified from their 
respective plasmids using the primers U6 forward (5′-TGGCGGGTGTATTAAACCAC-3′) 
and sgRNA reverse (5′-GGATTTCCTTACGCGAAATACG-3′) in reactions of final 
concentrations of 600 nM each primer, 300 μM dNTPs, 1 mM MgSO4, 2X buffer, and 0.05 
U/μl Platinum Pfx DNA polymerase (Life Technologies), and subjected to the following 
PCR program: an initial cycle of 3 minutes at 95°C, followed by 30 cycles of 30 seconds at 
94°C, 30s at 55°C and 2 minutes at 68°C, and a final cycle of 5 minutes at 68°C. 
U6>sgRNA(F+E)∷eGFP (STOLFI et al. 2014) was amplified as above but using Seq 
forward primer (5′-AGGGTTATTGTCTCATGAGCG-3′) instead. For phenotyping Ebf-
dependent expression of Islet reporter in MN2 motor neurons (STOLFI et al. 2014), 
embryos were co-electroporated with 35–40 μg of Sox1/2/3> nls∷Cas9∷nls, 5–15 μg of 
Sox1/2/3>H2B∷mCherry/eGFP, 30–40 μg of Isl>eGFP/mCherry, and either 25 μg of 
U6>Ebf.3 plasmid or 25 μl (~2.5 ug) of unpurified PCR product.
sgRNA expression cassette assembly by One-step Overlap PCR (OSO-PCR)
sgRNA PCR cassettes were constructed using an adapted One-step Overlap PCR (OSO-
PCR) protocol (Urban et al. 1997). Basically, a desired protospacer sequence is appended 5′ 
to a forward primer (5′-GTTTAAGAGCTATGCTGGAAACAG-3′) and its reverse 
complement is appended 5′ to a reverse primer (5′-ATCTATACCATCGGATGCCTTC-3′). 
These primers are then added to a PCR reaction at limiting amounts, together with u6 
forward (5′-TGGCGGGTGTATTAAACCAC-3′) and sgRNA reverse (5′-
GGATTTCCTTACGCGAAATACG-3′) primers and separate template plasmids containing 
the U6 promoter (U6>XX) and the sgRNA scaffold (XX>sgRNA F+E). Plasmids are 
available from Addgene (https://www.addgene.org/Lionel_Christiaen/). The 
complementarity between the 5′ ends of the inner primers bridges initially separate U6 and 
sgRNA scaffold sequences into a single amplicon, and because they are quickly depleted, 
the entire cassette is preferentially amplified in later cycles by the outer primers (see Figure 
5 and Supplementary Protocol for details). Final, unpurified reactions should contain PCR 
amplicon at ~100 ng/μl, as measured by image analysis after gel electrophoresis 
(Supplementary Figure 5).
Measuring mutagenesis efficacies of sgRNAs by Sanger sequencing
OSO-PCR cassettes were designed and constructed for the expression of 7 sgRNA targeting 
exons 10–12 that code for part of the IPT and HLH domains of Ebf (Figure 6a, 
Supplementary Table 3). Embryos were electroporated with 25 μl of unpurified OSO-PCR 
product and 25 μg Eef1a1>nls∷Cas9∷nls, and grown to hatching. For the replication 
experiment (Supplementary Table 6) 75 μg of sgRNA vectors (Gata4/5/6.2, Gata4/5/6.3, 
Gata4/5/6.4, Neurog.1, Neurog.2) were each co-electroporated with 25 μg 
Eef1a1>nls∷Cas9∷nls. This was repeated over two separate batches of embryos.
All larvae were allowed to hatch and genomic DNA was extracted using the QiaAmp DNA 
mini kit (Qiagen). The Ebf target region was PCR-amplified using the following primers: 
(Forward primer: 5′-CTCCACATGCCTCAACTTTG-3′, Reverse primer: 5′-
TGTTCCGCCAAATTGTGAAG-3′). For Gata4/5/6 target sequences, the primers used were 
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the corresponding ones from the NGS experiment, while a novel pair of primers was used to 
amplify the Neurog locus (Forward primer: 5′-AAGTACGGAGAGCAGAATACC-3′, 
Reverse primer: 5′-CTTCTAGTGCGTCATTAAGACC-3′). PCR was performed in 35 
cycles using Platinum Pfx DNA polymerase. The resulting PCR products were gel- or 
column-purified, and sequenced using either a flanking PCR primer or an internal 
sequencing primer (Ebf internal: 5′-AATTGGCTGACAGGTTGGAG-3′, Neurog internal: 
5′-GCTCTTGCTACAAAATGTTGG-3′).
The resulting.ab1 sequencing files were then analyzed by ab1 Peak Reporter webtool (ROY 
and SCHREIBER 2014) (https://apps.thermofisher.com/ab1peakreporter/)(Supplementary 
Table 5). To quantify the peak “shifts” resulting from CRISPR/Cas9-induced short indels 
(Supplementary Figure 6), we calculated the sum of “maximum signal 7 scan filtered ratio” 
(MaxSig7Scan Sum) values of minor peaks at each position in a 30 bp window starting from 
the third bp in the target sequence from the PAM (the most likely Cas9 cut site). The mean 
MaxSig7Scan Sum was calculated across all 30 bp of this window, resulting in a “raw 
peakshift score”. The same was repeated for the 30 bp window immediately 5′ to the cut 
site in the sequencing read, for a peakshift “baseline” estimate. This baseline was subtracted 
from the raw peakshift score to give the “corrected peakshift score”, a relative quantification 
of indel frequency, and therefore of the mutagenesis efficacy of the sgRNA used.
Whole-exome sgRNA predictions in Ciona
We used all transcribed regions in the ENSEMBL 65 transcript models (AKEN et al. 2016), 
extended them by 200 bp on each side, searched for all possible NGG-20bp sgRNA targets 
in these sequences and ran them through the command-line version of CRISPOR 
(HAEUSSLER et al. 2016) which aligns 20mers using BWA (LI AND DURBIN 2009) in 
iterative mode, ranks off-targets by CFD or MIT scores and calculates the Fusi/Doench 2016 
efficiency scores (Fusi et al. 2015; Doench et al. 2016). Efficiency scores were also 
translated to percentiles for better ease of use, e.g. a raw Fusi/Doench score of 60 translates 
to the 80th percentile, meaning that 80% of scored guides are lower than 60. All results are 
then written to a UCSC BigBed file (Raney et al. 2014) for interactive visualization. The 
BigBed file can be loaded into all popular genome browsers, like Ensembl (Yates et al. 
2016), IGV (Robinson et al. 2011) or GBrowse (Stein et al. 2002). The track is available on 
the ci2 assembly on the UCSC Genome Browser (http://genome.ucsc.edu), in the track 
group “Genes and Gene Predictions”. The source code is available as part of the UCSC 
Genome Browser source tree at: https://github.com/ucscGenomeBrowser/kent/tree/
master/src/hg/makeDb/crisprTrack
Embryo imaging
Fluorescent in situ hybridization of eGFP or Foxf coupled to immunohistochemsitry was 
carried out as previously described (Beh et al. 2007; Stolfi et al. 2014). Images were taken 
on a Leica Microsystems inverted TCS SP8 X confocal microscope or a Leica DM2500 
epifluorescence microscope. Mouse monoclonal anti-β-Gal Z3781 (Promega, Madison, WI) 
was used diluted at 1:500. Goat anti-Mouse IgG (H+L) Secondary Antibody Alexa Fluor 
568 conjugate (Life Technologies) was used diluted at 1:500.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Activity of 83 sgRNAs targeting 23 genes in Ciona embryos was analyzed by 
next-generation sequencing
• A new method of sgRNA expression vector construction by One-Step Overlap 
PCR (OSO-PCR) was developed
• sgRNAs can be transcribed in vivo from electroporated unpurified PCR 
products
• A high correlation was found between varying activity of several Ebf sgRNAs 
and frequency of Ebf loss-of-function phenotype in F0
Gandhi et al. Page 21
Dev Biol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Next-Generation Sequencing approach to validating sgRNAs for use in Ciona embryos
a) Schematic for next-generation sequencing approach to measuring mutagenesis efficacies 
of sgRNAs expressed in F0 Ciona embryos. See results and materials and methods for 
details. b) Representative view in IGV browser of coverage (grey areas) of sequencing reads 
aligned to the reference genome. “Dip” in coverage of reads from embryos co-electroporated 
with Eef1a1>Cas9 and U6>Htr7-r. 1 sgRNA vector indicates CRISPR/Cas9-induced indels 
around the sgRNA target site, in the 2nd exon of the Htr7-related (Htr7-r) gene. Colored bars 
in coverage indicate single-nucleotide polymorphisms/mismatches relative to reference 
genome. c) Diagram representing a stack of reads bearing indels of various types and sizes, 
aligned to exact target sequence of Htr7-r. 1 sgRNA. d) Plot of mutagenesis efficacy rates 
measured for all sgRNAs, ordered from lowest (0%) to highest (59.63%). Each bar 
represents a single sgRNA. e) Box-and-whisker plots showing the size distribution of 
insertions and deletions caused by Ebf.3 or Lef1.2 sgRNAs.
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Figure 2. Correlations between sgRNA sequence composition and mutagenesis efficacy
a) WebLogos representing the nucleotide composition at each variable position of the 
protospacer (nt 2–20, X axis), in top 25% and bottom 25% performing sgRNAs. b) Log-
odds scores depicting the frequency of occurrence for nucleotides in the top 25% and bottom 
25% sgRNAs, at all positions of the protospacer, PAM, and flanking regions. Position “1” of 
the protospacer has been omitted from the analysis, due to this always being “G” for PolIII-
dependent transcription of U6-promoter-based vectors. Likewise, the “GG” of the PAM has 
also been omitted, as this sequence is invariant in all targeted sites. Positive and negative 
log-odds scores reflect abundance and depletion, respectively, of a specific nucleotide at a 
given position relative to its random occurrence in our sample space. See materials and 
methods for details.
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Figure 3. Using Fusi/Doench scores to predict mutagenesis efficacies of sgRNAs in Ciona
a) Mutagenesis efficacy rate of each sgRNA plotted against the same sgRNA’s Fusi/Doench 
algorithm score, obtained from CRISPOR. The Spearman’s rank correlation coefficient (rho) 
is 0.435 (p = 3.884e-05). b) sgRNAs grouped by sorted Fusi/Doench predicted scores (left: 
>60; right: <50). 18 of 23 sgRNAs of Fusi/Doench score over 60 showed a measured 
mutagenesis efficacy (MUT%) over 24%, classified as “good” (shaded green). In contrast, 
only 4 from the same set had a MUT% under 24%, classified as “bad”. “Good” and “bad” 
classifications were based on phenotype frequency in F0 (see text for details). Out of 25 
sgRNAs with Fusi/Doench score under 50, 17 were “bad”, while only 8 were “good”. c) A 
Receiver Operating Characteristic (ROC) curve assesses the credibility of using Fusi/Doench 
score cutoff (from 0 to 100) to classify sgRNAs as either “good” (>24.5% efficacy) or “bad” 
(≤24.5% efficacy). Using Fusi/Doench cutoffs as such a classifier returns an AUC of 0.77 
(black line), while an AUC of 0.5 (dashed red line) represents the performance of a classifier 
solely based on random chance. The optimal Fusi/Doench cutoff (above which a score is 
likely to indicate “good” sgRNAs) was found to be between 50 and 55. See materials and 
methods and Supplementary Table 2 for details.
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Figure 4. Combinatorial targeting of Foxf results in large deletions
a) Diagram of Foxf locus, showing positions targeted by Foxf.4 and Foxf.2 sgRNAs. Foxf.4 
targets a non-coding, cis-regulatory sequence 881 base pairs (bp) upstream of the 
transcription start site of Foxf. Foxf.2 targets a coding sequence in exon 1 of Foxf. The 
distance between the target sites is 2132 bp, and encompasses most of exon 1, the core 
promoter, and cis-regulatory modules that drive Foxf expression in the head epidermis and 
trunk ventral cells (TVCs) (BEH et al. 2007). Blue arrows indicate primers used to amplify 
the region between the target sites. In wild-type embryos, the resulting PCR product is ~2.4 
kilobase pairs (kbp). b) Alignment of cloned PCR products amplified using the primers 
indicated in (a), from wild-type (wt) embryos, and from embryos electroporated with 25 μg 
Eef1a1>nls∷Cas9∷nls and 50 μg each of U6>Foxf.2 and U6>Foxf.4. Colonies 03, 04, and 06 
shown containing large deletions between the approximate sites targeted by the two 
sgRNAs, indicating non-homologous end-joining (NHEJ) repair from two separate double 
stranded break events as a result of combinatorial action of Foxf.2 and Foxf.4 sgRNAs. c) In 
situ hybridization for Foxf (green) showing strong expression throughout the head epidermis 
in embryos electroporated with 10 μg Fog>H2B∷mCherry (red), 50 μg Fog>nls∷Cas9∷nls 
and 45 μg of U6>Ebf.3. Foxf expression is essentially wild-type, as Ebf function is not 
required for activation of Foxf in the epidermis. d) In situ hybridization for Foxf (green) 
showing patchy expression in the head epidermis of embryos electroporated with 10 μg 
Fog>H2B∷mCherry (red), 50 μg Fog>nls∷Cas9∷nls and 45 μg each of U6>Foxf.2 and 
U6>Foxf.4. Loss of in situ signal in some transfected head epidermis cells indicates loss of 
Foxf activation, presumably through deletion of all or part of the upstream cis-regulatory 
sequences by CRISPR/Cas9. Scale bars = 25 μm.
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Figure 5. One-step Overlap Polymerase Chain Reaction (OSO-PCR) for the high-throughput 
construction of sgRNA expression cassette libraries
a) Diagram of OSO-PCR for amplification of U6>sgRNA expression cassettes in which the 
target-specific sequence of each (red) is encoded in complementary overhangs attached to 
universal primers. 1:10 dilution of these primers ensures that the overlap product, the entire 
U6>sgRNA cassette, is preferentially amplified (see methods for details). b) Agarose gel 
electrophoresis showing products of four different U6>sgRNA OSO-PCRs. The desired 
product is ~1.2 kilobase pairs (kbp) long. 2logL = NEB 2-Log DNA ladder. c) Detailed 
diagram of how the overlap primers form a target-specific bridge that fuses universal U6 
promoter and sgRNA scaffold sequences.
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Figure 6. Linear relationship between sgRNA efficacy and mutant phenotype frequency in F0
a) Diagram of Ebf locus, showing exons coding for DNA-binding (DBD), IPT, and helix-
loop-helix (HLH) domains. Colored dots indicate exons targeted by the Ebf-targeting 
sgRNAs used to validate the OSO-PCR method for genetic loss-of-function. b) Larvae co-
electroporated with Sox1/2/3>nls∷Cas9∷nls, Islet>eGFP, and 25 μl (~2.5 μg) unpurified 
U6>NegativeControl PCR or c) 25 μl (~2.5 μg) unpurified U6>Ebf.3 PCR, or d) 25 μg 
U6>Ebf.3 plasmid. Islet>eGFP reporter plasmid is normally expressed in MN2 motor 
neurons (“Islet+ MN2”, green), which is dependent on Ebf function. Islet>eGFP was 
expressed in MN2s in 75 of 100 negative control embryos. In embryos electroporated with 
unpurified U6>Ebf.3 PCR products or U6>Ebf.3 plasmid, only 16 of 100 and 17 of 100 
embryos, respectively, had Islet>eGFP expression in MN2s. This indicates similar loss of 
Ebf function in vivo by either unpurified PCR or purified plasmid sgRNA delivery method. 
c) Plot comparing mutagenesis efficacies of the OSO-PCR-generated sgRNAs indicated in 
panel (a) (measured by Sanger sequencing, see text for details) and the ability to cause the 
Ebf loss-of-function phenotype (loss of Islet>mCherry reporter expression in MN2s in 
Sox1/2/3>H2B∷eGFP+ embryos). The nearly perfect inverse correlation between sgRNA 
mutagenesis efficacy and Islet>mCherry expression indicates a linear relationship between 
sgRNA activity and mutant phenotype frequency in electroporated embryos. Ebf.3 sgRNA 
data point is bracketed, because its mutagenesis efficacy was not measured by Sanger 
sequencing but comes from the NGS data collected in this study.
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Table 1
Genes targeted for CRISPR/Cas9-mediated mutagenesis
The 23 genes targeted in the initial screen, each identified here by official gene symbol, aliases, and 
KyotoHoya identifier.
# Gene Symbol Aliases 2012 KyotoHoya ID
1 Bmp2/4 Bone morphogenetic protein 2/4 KH.C4.125
2 Ddr Discoidin Domain Receptor Tyrosine Kinase 1/2 KH.C9.371
3 Ebf Collier/Olf/EBF; COE KH.L24.10
4 Eph.a Ephrin type-A receptor.a; Eph1 KH.C1.404
5 Ets.b Ets/Pointed2 KH.C11.10
6 Fgf4/6 Fibroblast growth factor 4/6; FGF, unassigned 1 KH.C1.697
7 Fgf8/17/18 Fibroblast growth factor 8/17/18 KH.C5.5
8 Fgfr Fibroblast growth factor receptor KH.S742.2
9 Foxf FoxF KH.C3.170
10 Foxg-r Foxg-related; Orphan Fox-4; Ci-ZF248 KH.C5.74
11 Fzd5/8 Frizzled5/8 KH.C9.260
12 Gata4/5/6 GATA-a KH.L20.1
13 Hand Heart And Neural Crest Derivatives Expressed 1/2 KH.C14.604
14 Hand-r Hand-related; Hand-like; NoTrlc KH.C1.1116
15 Htr7-r 5-Hydroxytryptamine Receptor 7-related KH.S555.1
16 Isl Islet1/2 KH.L152.2
17 Lef1 Lef/TCF KH.C6.71
18 Mrf Muscle regulatory factor; MyoD KH.C14.307
19 Neurog Neurogenin; Ngn KH.C6.129
20 Nk4 Nkx2-5; Tinman KH.C8.482
21 Rhod/f RhoD/F; Rif KH.C1.129
22 Tle.b Groucho2 KH.L96.50
23 Tll Tolloid-like; Tolloid KH.C12.156
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